UBS O'Connor’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $446K | Buy |
+11,000
| New | +$446K | 0.02% | 250 |
|
|
2023
Q4 | – | Sell |
-55,262
| Closed | -$982K | – | 533 |
|
|
2023
Q3 | $982K | Sell |
55,262
-48,000
| -46% | -$853K | 0.02% | 326 |
|
|
2023
Q2 | $1.87M | Buy |
103,262
+5,087
| +5% | +$91.9K | 0.04% | 307 |
|
|
2023
Q1 | $1.23M | Buy |
+98,175
| New | +$1.23M | 0.03% | 381 |
|
|
2022
Q4 | – | Sell |
-61,000
| Closed | -$1.04M | – | 290 |
|
|
2022
Q3 | $1.04M | Buy |
+61,000
| New | +$1.04M | 0.01% | 730 |
|